x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    Technology

    Where Advanced Science Meets AI-Powered Precision

    At 1Cell.Ai, technology is at the core of how we redefine cancer diagnostics. Our platform merges cutting-edge innovations in molecular science, single cell analysis, bioinformatics, and artificial intelligence—delivering real-time, actionable insights to clinicians, researchers, and biopharma and pharma partners worldwide.

    Core Technology Pillars

    AI-Driven Insights

    Machine learning models optimized for real-time molecular interpretation.

    Single Cell Multi-Omics

    True single-cell resolution across genomics, transcriptomics, and proteomics.

    Integrated Bioinformatics

    Dynamic multi-omics data processing and interpretation at scale.

    Scalable Precision Platform

    Built to support research, diagnostics, and clinical deployment worldwide.

    AI-Powered Precision Oncology

    We leverage advanced machine learning and AI algorithms designed specifically for oncology. Our AI models analyze complex genomic, transcriptomic, and proteomic data, providing:

    By integrating AI at every step, we enable faster, more accurate decision-making in precision oncology.

    Real-time molecular insights for treatment selection

    Predictive analytics to assess therapy response and resistance

    Pattern recognition across large-scale clinical datasets

    Automated, scalable interpretation of multi-omics biomarkers

    Technology at Work: AI Meets Multi-omics

    Redefining the Future of Cancer Care OneCell Ai’s technology is driving a new standard in oncology, drug development, and precision medicine. By unlocking cell-level intelligence with AI, we empower healthcare professionals with the tools needed to make smarter, faster, and more personalized treatment decisions.

    Next-Generation Sequencing (NGS)

    High-throughput genomic analysis.

    Machine Learning & Bioinformatics

    AI models trained on diverse oncology datasets.

    Data-Driven Biomarker Discovery ​

    Multiomics insights for precision treatment planning.

    Collaboration

    Cross-functional platforms connecting clinicians and oncologists, researchers and labs pharma and bio-pharma partners

    The Evolution of Cancer Diagnostics

    Three generations of biopsy innovation, transforming how cancer is detected, monitored, and treated.

    Gen 1

    Tissue Biopsy

    Foundation of Precision Oncology

    • Gold standard
    • Direct tissue sampling
    • Histological & molecular profiling
    • Multi-omic data (static)

    Gen 2

    Liquid Biopsy

    Convenience and Accessibility

    • Non-invasive blood draw
    • Longitudinal monitoring
    • Tumor burden quantification
    • Real-time insights

    Gen 3

    Cell Biopsy

    Single Cell Precision

    • Captures live CTCs from blood
    • True single cell resolution
    • Reveals tumor complexity & evolution
    • Multi-omic data (dynamic)

    Built for Precision, Backed by Science

    Single Cell Genomics

    Understanding Cancer at Its Core

    Traditional bulk sequencing often overlooks key variations. Our platform uses true single-cell resolution to analyze individual tumor cells—unlocking powerful insights into:

    • Tumor heterogeneity
    • Rare mutations and subclonal populations
    • Real-time monitoring of tumor evolution
    • Guidance for personalized, adaptive therapy strategies

    Bioinformatics & Data Science

    Making Complex Data Clinically Actionable

    Our bioinformatics engine bridges the gap between raw data and clinical insight. Key capabilities include:

    • Multi-omics data integration across modalities
    • Advanced visualization and modeling tools
    • Custom AI algorithm development
    • Scalable infrastructure for clinical trials, research and diagnostics

    Platform Advantages

    Designed for Flexibility, Built for Impact

    Our technology platform is optimized for clinical environments, research workflows, and real-world implementation:

    • Non-Invasive & Real-Time
      Liquid biopsy and single-cell workflows reduce need for surgical procedures
    • Clinically Validated
      Rigorous internal validation and regulatory compliance
    • Scalable & Modular
      Adaptable across labs, trials, and care systems
    • Tailored for Oncology
      Purpose-built for the complexities of cancer care

    Leading the Future of Cell Science and Data Innovation

    At OneCell Ai, we are committed to staying at the forefront of cell science and data science innovations. Our comprehensive genomic solutions integrate Next-Generation Sequencing (NGS) with advanced bioinformatics, AI, machine learning, and data analytics to uncover multi-omics biomarkers for improved cancer management. Every genomic result is meticulously reviewed by our scientific board, ensuring that quality-driven insights lead to personalized and effective treatment decisions. Backed by state-of-the-art laboratory equipment and computational tools, we empower clinicians to make informed choices with precision and confidence.
    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.